Brief: Inspira™ Technologies Oxy BHN Signs A Strategic Agreement In Europe To Potentially Provide $26.1 For Deployment Of 1,364 Hyla™ Blood Sensors
22/11/2022 14:07
Nov 22 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA™ TECHNOLOGIES SIGNS A STRATEGIC AGREEMENT IN
EUROPE TO
POTENTIALLY PROVIDE $26.1 FOR DEPLOYMENT OF 1,364 HYLA™ BLOOD
SENSORS
* INSPIRA TECHNOLOGIES OXY BHN LTD - AGREEMENT SIGNED WITH
INNOVIMED IS OVER A 5-YEAR PERIOD, SUBJECT TO REGULATORY
APPROVALS
* INSPIRA TECHNOLOGIES OXY BHN LTD - HAS SIGNED AN EXCLUSIVE
DISTRIBUTION AGREEMENT FOR HYLA(™) BLOOD SENSOR WITH INNOVIMED
SP. Z O.O
Source text for Eikon: ID:nPn4jlcQxa
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM